Pharmaceuticals Global On demand · 24-48h

Global Pressure Injectable PICC Kit Market Strategic Research Report

Global Pressure Injectable PICC Kit Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pressure Injectable PICC Kit Market
$3922025
3.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Power Injected PICC, Conventional PICC

By Application: Hospitals, Nursing Facilities, Home Care, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: AngioDynamics, Inc., C. R. Bard Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic plc, Vygon S.A, Cook Medical, Inc., Boston Scientific Corporation, Argon Medical Devices, Inc., Medical Component, Inc., Theragenics Corporation

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 112 pages
Market size 2025
$392
Million USD
Forecast CAGR
3.3%
2025-2032
Forecast 2032
$492
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Pressure Injectable PICC Kit market size is predicted to grow from US$ 392 million in 2025 to US$ 491 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.

A peripherally inserted central catheter is a peripherally inserted central venous catheter manufactured using medical grade, flexible polyurethane. It is suitable for male and female to use for long-duration. It is used for intravenous therapy, pressure injection, infusion, blood sampling, of contrast media and allows for the central venous pressure monitoring. The kit assists the clinician in maintaining maximal sterile barrier precautions. Wherever there are device-related infections or thrombosis in the intended injection vessel or catheter route, the Pressure Injectable PICC is contraindicated. To ensure there are no contraindications, a clinical assessment of the patient must be performed.

Chronic diseases such as cancer, cardiovascular diseases, and infectious diseases often require long-term intravenous therapy and frequent administration of medications. Pressure Injectable PICC (Peripherally Inserted Central Catheter) kits are commonly used for such purposes, providing a reliable and convenient pathway for medication administration and blood sampling. The growing prevalence of chronic diseases worldwide is driving the demand for Pressure Injectable PICC kits. Pressure Injectable PICC kits offer several advantages over traditional intravenous access devices, such as peripheral IV catheters and central venous catheters. These include longer dwell time, reduced risk of complications, improved patient comfort, and better cost-effectiveness. As healthcare providers recognize the benefits of Pressure Injectable PICC kits, there is an increasing adoption of these devices, contributing to market growth. The global population of older adults is increasing, leading to a higher incidence of chronic diseases and age-related conditions that require long-term intravenous therapy. Pressure Injectable PICC kits are commonly used in geriatric care settings due to their ease of use and long-term access capabilities. The growing elderly population is a significant driver for the market, as it fuels the demand for Pressure Injectable PICC kits. There is a growing trend towards home healthcare, driven by factors such as cost-effectiveness, convenience, and the desire for patient-centered care. Pressure Injectable PICC kits are well-suited for home healthcare settings, allowing patients to receive intravenous therapy or medication administration in the comfort of their own homes. The increasing focus on home healthcare is contributing to the demand for Pressure Injectable PICC kits. Manufacturers are continually developing and improving the design of Pressure Injectable PICC kits to enhance their performance and patient safety. This includes features such as antimicrobial coatings, improved catheter materials, and integrated pressure injectable ports. Technological advancements in catheter design are driving the market as healthcare providers seek more reliable and advanced devices for intravenous access. Increasing awareness regarding the benefits of Pressure Injectable PICC kits and training programs for healthcare professionals in their use and maintenance are driving market growth. Recognizing the importance of proper catheter selection and insertion techniques, healthcare facilities are investing in training programs to ensure safe and effective use of Pressure Injectable PICC kits. Reimbursement policies and coverage for Pressure Injectable PICC kits vary across different regions. However, there is an increasing trend towards favorable reimbursement policies for intravenous therapy and related devices. This encourages healthcare providers and facilities to adopt Pressure Injectable PICC kits, further driving market growth.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pressure Injectable PICC Kit market?

What factors are driving Pressure Injectable PICC Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pressure Injectable PICC Kit market opportunities vary by end market size?

How does Pressure Injectable PICC Kit break out by Type, by Application?

This report presents a comprehensive overview of the global Pressure Injectable PICC Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Power Injected PICC
  • Conventional PICC

Segment by Application

  • Hospitals
  • Nursing Facilities
  • Home Care
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pressure Injectable PICC Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Nursing Facilities, Home Care evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pressure Injectable PICC Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$392
2025
Forecast
$492
2032
CAGR
3.3%
2025–2032
Gebieden
5
global
Key companies
AngioDynamics, Inc.C. R. Bard Inc.Teleflex IncorporatedB. Braun Melsungen AGMedtronic plcVygon S.ACook Medical, Inc.Boston Scientific Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Power Injected PICCConventional PICC
By Application
HospitalsNursing FacilitiesHome CareOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Power Injected PICC
  • 3.1.3 Conventional PICC
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Nursing Facilities
  • 4.1.4 Home Care
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 AngioDynamics, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 C. R. Bard Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Teleflex Incorporated
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 B. Braun Melsungen AG
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Medtronic plc
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Vygon S.A
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cook Medical, Inc.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Boston Scientific Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Argon Medical Devices, Inc.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Medical Component, Inc.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Theragenics Corporation
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Pressure Injectable PICC Kit market size?
The global Pressure Injectable PICC Kit market is estimated at US$ 392 million in 2025 (base year) and is projected to reach US$ 491 million by 2032.
What growth rate is expected for the Pressure Injectable PICC Kit market through 2032?
The market is expected to grow at a CAGR of 3.3% from 2026 to 2032, expanding from US$ 392 million in 2025 to US$ 491 million in 2032, roughly 1.3 times its base-year value.
How is Pressure Injectable PICC Kit defined?
A peripherally inserted central catheter is a peripherally inserted central venous catheter manufactured using medical grade, flexible polyurethane. It is suitable for male and female to use for long-duration. It is used for intravenous therapy, pressure injection, infusion, blood sampling, of contrast media and allows for the central venous pressure monitoring.
How is the Pressure Injectable PICC Kit market segmented by type?
By type, the market is segmented into Power Injected PICC and Conventional PICC.
What are the key applications of Pressure Injectable PICC Kit?
Key applications covered include Hospitals, Nursing Facilities, Home Care and Others.
Which companies are profiled in the Pressure Injectable PICC Kit market report?
Key players profiled include AngioDynamics, C. R. Bard Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic plc, Vygon S.A, Cook Medical and Boston Scientific Corporation, among 11 companies covered in total.
What geographies does the Pressure Injectable PICC Kit market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Pressure Injectable PICC Kit?
The growing prevalence of chronic diseases worldwide is driving the demand for Pressure Injectable PICC kits.
What are the main risks and barriers in the Pressure Injectable PICC Kit market?
The kit assists the clinician in maintaining maximal sterile barrier precautions.
Who should buy the Pressure Injectable PICC Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Nursing Facilities and Home Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pressure Injectable PICC Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.